MCQOPTIONS
Saved Bookmarks
MCQOPTIONS
This section includes 10 Mcqs, each offering curated multiple-choice questions to sharpen your Tissue Engineering knowledge and support exam preparation. Choose a topic below to get started.
| 1. |
Which of the following Tissue Engineering products has been approved by the European Medicines Agency (EMA) as an Advanced Therapy medicinal product (Drug)? |
| A. | ChondroCelect<sup> </sup> |
| B. | CarticelTM |
| C. | Provenge<sup> </sup> |
| D. | Laviv<sup> </sup> |
| Answer» B. CarticelTM | |
| 2. |
Name one 361 HCT/P which cannot be imported. |
| A. | Cartilage |
| B. | Bone |
| C. | Infected Peripheral Blood Stem Cells |
| D. | Cornea |
| Answer» B. Bone | |
| 3. |
_____________ need to register with FDA under Title 21 of Code of Federal Regulations (CFR). |
| A. | Laboratories doing speciation of microorganisms detected in HCT/P cultures |
| B. | Companies collecting Blood samples from donors |
| C. | School laboratories |
| D. | Hospitals storing HTC/Ps |
| Answer» B. Companies collecting Blood samples from donors | |
| 4. |
Umbilical cord blood stem cells are an example of 361 HCT/Ps that meet the criteria in Title 21 of CFR part 1271. |
| A. | True |
| B. | False |
| Answer» B. False | |
| 5. |
Which Act governs the manufacture of HCT/Ps? |
| A. | Public Health Service Act |
| B. | Food, Drug, and Cosmetic Act |
| C. | Food Adulteration Act |
| D. | Meat Food Products Order |
| Answer» B. Food, Drug, and Cosmetic Act | |
| 6. |
Title ______________ constitutes of a comprehensive regulatory Framework for the producers of human cells, tissues, and cellular and tissue-based products (HCT/Ps). |
| A. | 21 CFR Part 1271 |
| B. | 21 CFR Part 1308 |
| C. | 21 CFR Part 110 |
| D. | 21 CFR Part 111 |
| Answer» B. 21 CFR Part 1308 | |
| 7. |
Which is the Competent Authority for tissues and cells in the United Kingdom? |
| A. | Human Tissue Authority |
| B. | Health and Youth Care Inspectorate |
| C. | Medical Products Agency |
| D. | Slovenija-transplant |
| Answer» B. Health and Youth Care Inspectorate | |
| 8. |
Prosthetic devices are capable of restoring normal function, and the number of organ donors is always way less than required. |
| A. | True |
| B. | False |
| Answer» C. | |
| 9. |
The driving force behind the conceptualization of in vivo culturing of tissues was the limited number of donors available and graft-rejection by the immune system. |
| A. | True |
| B. | False |
| Answer» C. | |
| 10. |
What is the Goal of Tissue Engineering? |
| A. | Providing biological substitutes to maintain and improve the function of damaged tissues |
| B. | Cure or slow down a genetic disease by repairing the damaged gene responsible for the disease |
| C. | Restore structure and function of damaged tissues and organs |
| D. | Identifying basic genetic and molecular defects causing a disease, and developing <i>molecular</i> interventions to treat the same |
| Answer» B. Cure or slow down a genetic disease by repairing the damaged gene responsible for the disease | |